Zdrowie i gospodarka · 29/09/2020

FDA Releases Guidance on Breast Implant Labeling for Improved Patient Communication

The Food and Drug Administration (FDA) has released a final guidance document titled 'Breast Implants-- Certain Labeling Recommendations to Improve Patient Communication' to enhance patient understanding of breast implant benefits and risks. The guidance aims to complement physician-patient discussions, not replace them.